AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Oxaliplatin in South Africa
36 products registered with SAHPRA — 18 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| XILAZ 50 mg/10 ml | 56/26/0776.773 | Aurogen South Africa (Pty) Ltd | active | 6 Dec 2027 |
| RECOTAXIN 50 mg/10 ml | 56/26/0773 | Aurogen South Africa (Pty) Ltd | active | 6 Dec 2027 |
| RECOTAXIN 200 mg/40 ml | 56/26/0775 | Aurogen South Africa (Pty) Ltd | active | 6 Dec 2027 |
| RECOTAXIN 100 mg/20 ml | 56/26/0774 | Aurogen South Africa (Pty) Ltd | active | 6 Dec 2027 |
| XILAZ 100 mg/20 ml | 56/26/0777.774 | Aurogen South Africa (Pty) Ltd | active | 6 Dec 2027 |
| OXALIPLATIN 50 CIPLA | 47/26/1106 | Cipla Medpro (Pty) Ltd | suspended | 17 Jul 2025 |
| OXALIPLATIN MEDPRO 100 | 46/26/0478 | Cipla Medpro (Pty) Ltd | suspended | 17 Jul 2025 |
| OXALIPLATIN MEDPRO 50 | 46/26/0477 | Cipla Medpro (Pty) Ltd | suspended | 17 Jul 2025 |
| OXALIPLATIN 100 CIPLA | 47/26/1107 | Cipla Medpro (Pty) Ltd | suspended | 17 Jul 2025 |
| OXALIWIN 50 mg/10 ml RTU | A39/26/0521 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 22 May 2025 |
| OXALIWIN 100 mg/20 ml RTU | A39/26/0522 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 21 May 2025 |
| OXLIPLATIN KEY 100 | 45/26/0331 | Key Oncologics (Pty) Ltd | suspended | 21 May 2025 |
| OXALIPLATIN KEY 50 | 45/26/0330 | Key Oncologics (Pty) Ltd | suspended | 21 May 2025 |
| GOXYRAL 100 | 42/26/0597 | Pharmaplan (Pty) Ltd | suspended | 18 Mar 2025 |
| GOXYRAL 50 | 42/26/0596 | Pharmaplan (Pty) Ltd | suspended | 18 Mar 2025 |
| OXAVIATIN 50 mg/10 ml | 45/26/0934 | Safeline Pharmaceuticals (Pty) Ltd | suspended | 2 Nov 2023 |
| OXAVIATIN 200 mg/40 ml | 45/26/0936 | Safeline Pharmaceuticals (Pty) Ltd | suspended | 2 Nov 2023 |
| OXAVIATIN 100 mg/20 ml | 45/26/0935 | Safeline Pharmaceuticals (Pty) Ltd | suspended | 2 Nov 2023 |
| OXALIWIN 100 mg/20 ml | A390520 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 11 Jul 2023 |
| ELOXATIN 100 mg/20 ml | A39/26/0497 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 11 Jul 2023 |
| OXALIWIN 50 mg/10 ml | A39/26/0519 | Sanofi-Aventis South Africa (Pty) Ltd | suspended | 11 Jul 2023 |
| OXALIPLATIN "EBEWE" 50 mg | 41/26/0910 | Sandoz South Africa (Pty) Ltd | suspended | 21 Jan 2022 |
| OXALIPLATIN "EBEWE" 100 mg | 41/26/1129 | Sandoz South Africa (Pty) Ltd | suspended | 21 Jan 2022 |
| ASPEN OXALIPLATIN 50 mg/10 ml | 45/26/0921 | Pharmacare Limited û Woodmead | active | 1 Jan 1900 |
| OXALIPLATIN PCH 50 | 43/26/0102 | Teva Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| OXALIPLATIN PCH 100 | 43/26/0103 | Teva Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| INTAS-OXALIPLATIN 100 | 42/26/1066 | Eurolab (Pty) Ltd | active | 1 Jan 1900 |
| ELOPLAT 200 | 46/26/0922 | Sandoz South Africa (Pty) Ltd | active | 1 Jan 1900 |
| EXIPLAT 50 | 43/26/0165 | MSQ Pharma (Pty) Ltd | active | 1 Jan 1900 |
| ASPEN OXALIPLATIN 100 mg/20 ml | 45/26/0922 | Pharmacare Limited û Woodmead | active | 1 Jan 1900 |
| ELOPLAT 150 | 46/26/0921 | Sandoz South Africa (Pty) Ltd | active | 1 Jan 1900 |
| ELOPLAT 50 | 46/26/0919 | Sandoz South Africa (Pty) Ltd | active | 1 Jan 1900 |
| ELOPLAT 100 | 46/26/0920 | Sandoz South Africa (Pty) Ltd | active | 1 Jan 1900 |
| ASPEN OXALIPLATIN 200 mg/40 ml | 45/26/0923 | Pharmacare Limited û Woodmead | active | 1 Jan 1900 |
| INTAS-OXALIPLATIN 50 | 44/26/0380 | Eurolab (Pty) Ltd | active | 1 Jan 1900 |
| EXIPLAT 100 | 43/26/0166 | MSQ Pharma (Pty) Ltd | active | 1 Jan 1900 |
Oxaliplatin — SAHPRA Registration Details
SAHPRA (South Africa) has 36 registered products containing Oxaliplatin, of which 18 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Oxaliplatin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.